Identification and validation of ANXA3 and SOCS3 as biomarkers for acute myocardial infarction related to sphingolipid metabolism
Open Access
- 4 August 2025
- journal article
- research article
- Published by Springer Nature in Hereditas
- Vol. 162 (1) , 1-21
Abstract
Background: Sphingolipid metabolism (SM) is linked to acute myocardial infarction (AMI), but its role remains unclear. This study explored SM-related genes (SMRGs) in AMI to support clinical diagnosis. Methods: We analyzed datasets GSE48060 and GSE123342 to identify differentially expressed genes (DEGs) and key module genes. Protein-protein interaction (PPI) network analysis and machine learning were used to screen potential biomarkers, which were validated via receiver operating characteristic (ROC) curves and expression assessment. Further analyses included artificial neural networks (ANN), enrichment analysis, immune infiltration, drug prediction, and molecular docking. Single-cell RNA sequencing (scRNA-seq) identified key cell types and their functions. Biomarkers were validated via reverse transcription quantitative polymerase chain reaction (RT-qPCR). Results: Intersection of 95 DEGs and 2,196 module genes yielded 20 genes, with ANXA3 and SOCS3 identified as biomarkers. The ANN model showed superior diagnostic performance compared to individual markers. Biomarkers were enriched in the toll-like receptor (TLR) signaling pathway. Immune infiltration analysis revealed differences in five immune cell types between AMI and control groups. ANXA3 correlated positively with neutrophils and negatively with resting memory CD4 T cells. Drugs targeting ANXA3 included ethanolamine, difluocortolone, and fluocinolone acetonide, with strong binding affinity. scRNA-seq identified B cells and monocytes as key cells; ANXA3 and SOCS3 expression increased during monocyte differentiation before decreasing, while B cells showed no significant changes. Conclusion: ANXA3 and SOCS3 were identified as SM-related biomarkers in AMI, providing insights for clinical diagnosis.Keywords
Funding Information
- Clinical Key Specialty Construction Project of Zhejiang Province - - Cardiovascular Medicine (2024-ZJZK-001, 2024-ZJZK-001, 2024-ZJZK-001)
- Zhejiang Province Traditional Chinese medicine scientific research fund (2023ZL700, 2023ZL700)
This publication has 86 references indexed in Scilit:
- The potential role of sphingolipid-mediated cell signaling in the interaction between hyperglycemia, acute myocardial infarction and heart failureExpert Opinion on Therapeutic Targets, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Acidic Sphingomyelinase Controls Hepatic Stellate Cell Activation and in Vivo Liver FibrogenesisThe American Journal of Pathology, 2010
- Sphingomyelinases: their regulation and roles in cardiovascular pathophysiologyCardiovascular Research, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- The role of sphingomyelin cycle metabolites in transduction of signals of cell proliferation, differentiation and death.2000
- Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts.Journal of Biological Chemistry, 1992